Catalyst Wire Dossier Catalyst Wire Dossier

GSK 1557484A

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK 1557484A, covering 2014-02-07 to 2014-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults [Phase 1]

See pricing